Morgan Stanley
LHDX

Morgan Stanley’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Morgan Stanley’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-207,755
Closed -$23.1K – 7933
2022
Q4 		$23.1K Sell
207,755
-4,399
-2% -$2.81K ﹤0.01% 6627
2022
Q3 		$225K Buy
212,154
+197,022
+1,302% +$449K ﹤0.01% 5680
2022
Q2 		$28K Buy
15,132
+1,771
+13% +$4.3K ﹤0.01% 6862
2022
Q1 		$48K Buy
13,361
+803
+6% +$3.94K ﹤0.01% 6729
2021
Q4 		$109K Sell
12,558
-1,415
-10% -$9K ﹤0.01% 6391
2021
Q3 		$105K Buy
13,973
+1,925
+16% +$16.2K ﹤0.01% 6345
2021
Q2 		$80K Buy
12,048
+6,901
+134% +$43.5K ﹤0.01% 6451
2021
Q1 		$62K Buy
+5,147
New +$102K ﹤0.01% 6257

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return